KIORA PHARMACEUTICALS, INC. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, acquisitions for the quarter ending 2016-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, acquisitions for the quarter ending 2016-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, acquisitions for the quarter ending 2016-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, acquisitions for the quarter ending 2016-03-31 was $2.91M.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, acquisitions for fiscal 2021 was $67.94K.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, acquisitions for fiscal 2016 was $2.91M.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2021-12-31 | $67.94K 10-K · filed 2023-03-23 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $2.91M 10-K · filed 2018-03-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | |
| 2016-03-31 | $2.91M 10-Q · filed 2016-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |